Introduction
There has been a great deal of interest in the existence of a syndrome of chronic malaise following a viral infection (postviral syndrome, PVS)l. In the case of glandular fever it is now becoming accepted that a prolonged course of illness can occur before recovery". This may be characterized by the persistence of specific antigens in the bloodstream'', although this remains a controversial area'', This provides theoretical evidence for the possibility that other unidentified viruses may cause a similar syndrome. In particular, enteroviral infection has been proposed as one such precipitant 4 ,5. An enteroviral antigen (VP1) has been found in the serum of 51% of a group of patients diagnosed as having PVS on clinical grounds, and 53% of another group with PVS and positive enteroviral stool cultures''. However, since the symptoms are not specific, and can occur in both physical and psychological illnesses, making a definite clinical diagnosis of PVS is difficult. This study was designed to investigate the clinical, serological, and psychological features of people having a Monospot test, to see if any further insight can be obtained into this problem.
Subjects and methods

Study design
One hundred and fifty consecutive patients venesected at University College Hospital London (UCH) Haematology department for a Monospot test in December 1986 and January 1987 were requested to fill out a questionnaire and return it to us by post. This consisted of the 60 item General Health Questionnaire (GHQ)6, and a series of items on their medical status. A follow-up medical status questionnaire was sent 6 months later. In both cases a written request to fill out the questionnaire was sent to non-responders within 4 weeks. At the initial venesection serum was also frozen and later analysed for. the presence of a group specific enteroviral antigen (VP1) using a monoclonal antibody 5-D8/1 at St Mary's Hospital Medical School as previously described", The GHQ was scored using the 'GHQ scoring' method" with a cut off of 11/12 for psychological caseness, and a cut off of 4/5 for the subscales. Results were analysed using the x 2 test for discontinuous variables, and one and two way analysis of variance for the continuous variables.
Patients
Of the 150 patients, 36% were male and 63% were female. Overall the mean age was 24.5 years (s.d. 8.4 years, range 9-72 years). Eighty-seven were sent from two local University Health Centres, and the remaining 63 from other GPs, or outpatient clinics at UCH. Sixty-five were students, nurses, or student nurses, 36 were in other employment, three were unemployed, one retired, and two were still at school (missing data=43). One hundred and nine patients (72%) filled out an initial questionnaire, and 89 of these (82%) filled out a follow-up questionnaire. There was no difference between the 41 non-responders, the 20 people who filled out an initial questionnaire only, and the 89 people who filled out both an initial and a follow-up questionnaire, with respect to age (P=0. 6) or sex (P=0.5) or VPl result (P=0.14) . None of the first two groups had a positive Monospot compared to 12 of the 89 full responders. However, two of the non-responders and one of the initial responders had had a positive Monospot at some time during present illness, and using this for comparison there was then no difference between the groups (P=0.12). Although the 20 initial responders scored higher on the. GHQ (mean score 30.3, s.d.=13.2) than the 89 full responders (mean score 22. 1, s.d.=14.6) , this just failed to be significant (P=0.06) using a cut off of 11/12 for caseness. Only the 89 patients who responded to both the initial and the follow-up questionnaires will be considered further in detail. 
Results
Clinical classification
The 89 full responders were divided into five groups on the basis of their clinical history, duration of symptoms and final diagnosis.
Group 1 (n=40): Patients with an illness lasting less than 6 months who made a complete recovery. In this group there were a large number of non-specific diagnoses (flu, colds, run-down, stress etc.) and seven subjects with a positive Monospot test.
Group 2 (n=13):These patients had a specific diagnosis varying from earwax, foodallergy, to hypothyroidism, toxoplasmosis and AIDS-related complex. None of these were Monospot positive by definition. Table 2 . Initial symptoms Group 3 (n=14): These patients had an illness lasting more than 6 months following glandular fever or another viral illness, five being Monospot positive. At follow-up 6 months after the initial questionnaire, 10 out of the 14 subjects had improved but were not completely well. Details of this group are shown in Table 1 .
Group 4 (n=lO): These patients had recurrent sore throats/flu like illness for 6 months to 2 years, except for one patient with a lO-year history.
Group 5 (n=12): These patients had an indefinable illness variously called 'stress', 'virus', 'overwork' or 'don't know', ranging from 7 months to 3 years duration. Five were seriously affected and three remained so at follow-up. There was no significant difference between the groups with respect to age (P=0.80), sex (P=0.14), marital status ( P=0.66), occupation (students/nurses vs others) ( P=0.90), or GP (student health vs others) (P=0.73).
Initial symptoms
Patients in group 2 (specific diagnosis other than glandular fever) were less likely to present with symptoms of tiredness/fatigue (P< 0.001), sore throat (P=0.002), aching muscles/joints (P=0.002), loss of concentration (P=0.025), or fevers (P=0.018), than patients in the other groups, among whom the incidence of these symptoms did not differ ( Table 2) .
Monospot result
Twelve of the 89 patients (13%) had a positive Monospot result (Figure 1 ). Seven of these were in group 1 (short lasting illness), and presented within 4 weeks of the onset of symptoms. This is in agreement with the fact that the heterophil antibody titre is highest in the second and third week of the illness and then declines". Hence a negative Monospot result after 4 weeks does not exclude glandular fever. Conversely, the other five patients with a positive Monospot were in group 3 (prolonged ? viral illness of over 6 months duration), and presented after at least 4 weeks of symptoms (ie a positive Monospot after 4 weeks was associated with a prolonged course of illness of greater than 6 months).
There was no association bet~een a positive Monospot result and a duration of illness of over 6 months ( P= 1.0), making a complete recovery ( P=0.5), nor of a more severe illness ( P=0.07), although the latter approached significance. A complaint of swelling in the neck was more common in patients with a positive Monospot. It was present in 5 of 12 (42%)with a positive Monospot, but only 4 of 77 (5%) with a negative Monospot ( P=O.OOI). This is compatible with the prediliction of glandular fever to affect the cervical lymph glands",
VPl result
Serum samples for 144 of the patients were tested for the presence of a group specific enteroviral antigen (\'PI), 48 (33%) were positive. Among the 89 patients investigated in greater detail, 28 of 83 serum samples tested (34%)were VPl positive. This ranged from 15% in group 3 to 44% in group 1 (Figure 1 ).
There was no relationship between VPl positivity and the Monospot result in the total sample (P=0.591). However, in group 1, five of the seven (71%) patients with a positive Monospot were also VP1 positive, compared to 11 out of 31 (38%) who were Monospot negative. In group 3 (possible postviral syndrome) the two VPl positive patients were Monospot negative. In group 2 (specific diagnosis), the five VP1 positive patients were suffering from toxoplasmosis, AIDSrelated complex, hepatitis A, hypothyroidism and food allergy. There was no relationship between the VPl result and the duration of symptoms prior to the test or the total duration of the illness. A positive VPl result just failed to be significantly associated with making a full recovery ( P=0.053). Patients with a positive VPl result were more likely to complain of fevers (P=O.034). No other symptoms were related to the VPl result, although the occurrence of flu-like symptoms (P=0.081) and glands (P=0.080) approached significance.
Viral onset
Patients were asked at follow-up to recall whether their initial symptoms were those of a viral illness. Sixty-five per cent of those who responded (56 out of 86) answered yes: group 1, 74%; group 2, 31%; group 3, 77%; group 4, 67%; group 5,58%. Patients in group 2 were therefore less likely to recall a viral illness than the other groups (P=0.012). No other factors, eg positive Monospot (P=0.27), VP1 positivity ( P= 1.0), presentation within 4 weeks of onset (P= 1.0), or making a complete recovery (P=0.39), were associated with this. Reporting symptoms of fevers ( P< 0.001), sore throat ( P=0.002), flu ( P=0.006), and headache ( P=0.002), in the initial questionnaire were the only ones associated with recalling a viral onset at follow-up.
Psychological status: GHQ scores
The 60 item GHQ was scored using the 'GHQ score' method" with a cut off score of 11/12 for 'psychological caseness'. Twenty-eight ofthe 60 questions can be divided into four scales of seven questions each to reflect different parameters, which can then be analysed separately, and a cut off of 4/5 has been used".
Total GHQ score: Seventy-two per cent (64 out of 89) of the patients had a score above the cut off point of 11/12 suggested as a screening measure for 'psychological caseness'. Group 2 had the lowest number above the cut off (46%), but this failed to reach significance (P=0.057) <Figure 1).
GHQ subscales: Fifty-six of the 89 patients (63%) scored above the cut off of 4/5 on the somatic symptoms subscale (GHQ A). Group 2 had significantly fewer people scoring above this cut off (31%) than the other groups (P=0.022). There were no significant differences between the groups in the numbers scoring above the cut off on the other subscales: GHQ B anxiety and insomnia (28%), GHQ C social dysfunction (27%), GHQ D severe depression (8%). There was no significant difference in the total GHQ score, or the subscale scores, with regard to the Monospot or VP1 result, or the duration of the illness prior to answering the GHQ. A total score ofless than 12 just failed to reach significance for a complete recovery (P=0.057), but none of the subscales approached significance in making this distinction.
Discussion
The differential diagnosis of chronic non-specific symptoms includes social, psychological and physical causes or a complex inter-relationship of all three. Where no specific disease process can be identified (by current tests), a psychological aetiology may be suggested by the doctor. This diagnosis is often not accepted by the patient, and frequently received with less tolerance by family and friends. Furthermore, any psychological abnormality discovered could be secondary to an undiagnosed physical condition. These problems have been thrown into sharper focus by publicity about the 'postviral syndrome'. It is suggested that some patients complaining of chronic fatigue and malaise, are suffering from the continuing effects of an initial viral infection. Since the symptoms are not specific, a clinical diagnosis is difficult to either prove or refute in a particular patient. A search for laboratory features of the illness is therefore underway. Methodological problems remain however, in that interpreting laboratory findings when the clinical diagnosis is unproven, is open to question. These problems have bedevilled the diagnosis of chronic Epstein-Barr virus infection", although this is more widely accepted as a real entity2, and is the basis for suggesting that other as yet unidentified viruses may cause a similar syndrome.
In this study, nine patients with a positive Monospot during their present illness, had a prolonged course, which was severely disruptive to their lives in at least two cases, and five others had a possible postviral syndrome without serological evidence of glandular Journal of the Royal Society of Medicine Volume 82 December 1989 715 fever. This study agreed with previous larger surveys that a positive Monospot test may only be present within the first 4 weeks of the illness". One patient had four Monospot tests over a period of 8 months, only the second and fourth being positive. Hence a single Monospot test, particularly if not performed within the first 4 weeks of the illness may miss the diagnosis. Conversely, a positive Monospot after 4 weeks of symptoms was associated with a prolonged course of illness.
The recent finding of a group specific enteroviral antigen in the serum of half of two groups of patients diagnosed as having PVS, but not in controls" provides a new avenue for research. In this study 33% of these patients sent for a Monospot test by their doctor (ie with an acute or chronic viral illness suspected as a possible diagnosis) were positive for the VP1 antigen. Although two of five patients with possible PVS who were Monospotnegative throughout their present illness, were positive for VP1, this was not specific to this group, and VP1 positive patients were found among the other four groups as well, particularly group 1 (acute, self-limiting illness) and group 2 (definite diagnosis except glandular fever), and in patients with fevers (P=0.034). This may reflect acute infection, but it also suggests that VPl positivity is found in circumstances other than in PVS and its interpretation must be made with care.
We were unable to identify any symptoms which were specific to the 'PVS' group. The group of patients in whom a specific diagnosis was made (other than patients with glandular fever) differed from the rest in being less likely to present with fevers, aching muscles/joints, sore throat, tiredness/fatigue or loss of concentration, and it may therefore be advisable to concentrate on looking for a specific diagnosis in patients without these symptoms.
Sixty-five per cent of patients in this study recalled a precipitating viral infection, so that the specificity of this finding may be too low to be of use in defining a postviral group, although again group 2 (specific illnesses) behaved differently from the other groups with fewer people recalling a viral start to their illness.
An attempt was made in this study to assess the psychological status of the patients using the General Health Questionnaire (GHQ), which is a selfadministered 60 question screening test designed to detect psychological disorders in a medical setting, eg a GP surgery or medical outpatients". Sixty-four of 89 patients (72%) had a score above the threshold for 'psychological caseness', considerably higher than in other studies carried out in a community or primary health care setting", This may be caused in part by the physical symptoms of the patients", It did not distinguish those with a self-limiting illness from those with a chronic one, nor patients with a possible postviral syndrome from those without any specific features. Its usefulness in this context is therefore likely to be limited.
This study demonstrates the considerable difficulties in making a diagnosis in patients with chronic non-specificsymptoms, and clearly the 'organic versus functional' debate is likely to continue, although its relevance has been questioned.
